Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity.
about
Dendritic cell-derived interleukin-15 is crucial for therapeutic cancer vaccine potency.Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response.Cellular immunotherapy for carcinoma using genetically modified EGFR-specific T lymphocytes.Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.
P2860
Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Genetic targeting of the activ ...... herapeutic antitumor immunity.
@ast
Genetic targeting of the activ ...... herapeutic antitumor immunity.
@en
type
label
Genetic targeting of the activ ...... herapeutic antitumor immunity.
@ast
Genetic targeting of the activ ...... herapeutic antitumor immunity.
@en
prefLabel
Genetic targeting of the activ ...... herapeutic antitumor immunity.
@ast
Genetic targeting of the activ ...... herapeutic antitumor immunity.
@en
P2093
P2860
P356
P1433
P1476
Genetic targeting of the activ ...... herapeutic antitumor immunity.
@en
P2093
Cara Donahue
Louis D Falo
Shenghe Tian
Zhaoyang You
Zuqiang Liu
P2860
P304
P356
10.1038/MT.2011.183
P577
2011-09-20T00:00:00Z